文献速递物质与行为成瘾

物质使用障碍的临床、环境与遗传风险因素:多队列联合效应分析

Clinical, environmental, and genetic risk factors for substance use disorders: characterizing combined effects across multiple cohorts.
PubMed 文献 · Mol Psychiatry · 2022-01-01

该研究在四个纵向队列共15,134名年轻成人中检验临床环境风险指数(CERI)与多基因评分(PGS)联合识别物质使用障碍(SUD)风险的能力。CERI与酒精、尼古丁、药物依赖均相关(OR=1.37–1.67),PGS相关但增量有限(OR=1.09–1.33),全模型解释6–13%变异。联合指标区分能力 modest,尚不足以临床应用。

要点

  • CERI与酒精、尼古丁、药物依赖均显著相关,OR为1.37–1.67。
  • PGS显著但增量有限,全模型仅解释6–13%的SUD变异。
  • CERI与PGS均在前10%者相对风险为3.86–8.04,但整体区分能力有限。

核心结论

  • 联合临床环境与遗传风险可识别年轻成人SUD高风险个体,但区分能力有限,尚不足以临床应用。

研究设计与样本

  • 四个纵向队列联合样本N=15,134,含欧洲 ancestry 12,659人与非洲 ancestry 2,475人。

主要发现

  • CERI与酒精依赖、尼古丁依赖、药物依赖均相关,OR=1.37–1.67。
  • 问题性饮酒PGS与酒精依赖相关,外化PGS与药物依赖相关,吸烟量PGS与尼古丁依赖相关,OR=1.11–1.33。
  • 问题性饮酒与外化PGS也与任何物质依赖相关,OR=1.09–1.18。
  • 全模型解释SUD变异的6–13%。
  • CERI与PGS均处于前10%者相对底部90%的相对风险比为3.86–8.04。

关键数值与推荐

  • SUD结局包括酒精依赖、尼古丁依赖、药物依赖及任何物质依赖。
  • 模型包含CERI与PGS,CERI与所有三种结局相关(OR=1.37–1.67)。
  • PGS显著但相对CERI增量贡献小。

临床怎么用

  • 目前联合风险评分仅具 modest 区分能力,暂不推荐用于临床常规风险分层。

局限性

  • 仅纳入欧洲与非洲 ancestry 参与者,其他人群外推性未知。
  • 全模型解释方差仅6–13%,区分能力有限。
  • PGS相对CERI增量贡献小,联合工具距临床应用仍有距离。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Substance use disorders (SUDs) incur serious social and personal costs. The risk for SUDs is complex, with risk factors ranging from social conditions to individual genetic variation. We examined whether models that include a clinical/environmental risk index (CERI) and polygenic scores (PGS) are able to identify individuals at increased risk of SUD in young adulthood across four longitudinal cohorts for a combined sample of N = 15,134. Our analyses included participants of European (NEUR = 12,659) and African (NAFR = 2475) ancestries. SUD outcomes included: (1) alcohol dependence, (2) nicotine dependence; (3) drug dependence, and (4) any substance dependence. In the models containing the PGS and CERI, the CERI was associated with all three outcomes (ORs = 01.37-1.67). PGS for problematic alcohol use, externalizing, and smoking quantity were associated with alcohol dependence, drug dependence, and nicotine dependence, respectively (OR = 1.11-1.33). PGS for problematic alcohol use and externalizing were also associated with any substance dependence (ORs = 1.09-1.18). The full model explained 6-13% of the variance in SUDs. Those in the top 10% of CERI and PGS had relative risk ratios of 3.86-8.04 for each SUD relative to the bottom 90%. Overall, the combined measures of clinical, environmental, and genetic risk demonstrated modest ability to distinguish between affected and unaffected individuals in young adulthood. PGS were significant but added little in addition to the clinical/environmental risk index. Results from our analysis demonstrate there is still considerable work to be done before tools such as these are ready for clinical applications.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Barr PB, Driver MN, Kuo SI, et al. Clinical, environmental, and genetic risk factors for substance use disorders: characterizing combined effects across multiple cohorts. Mol Psychiatry. 2022. PMID: 36195638. doi:10.1038/s41380-022-01801-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。